Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 012265
Company: SCHERING

Products on NDA 012265

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
NAQUA	TRICHLORMETHIAZIDE	2MG	TABLET;ORAL	Discontinued	None	No	No
NAQUA	TRICHLORMETHIAZIDE	4MG	TABLET;ORAL	Discontinued	None	No	No
NAQUIVAL	RESERPINE; TRICHLORMETHIAZIDE	0.1MG;4MG	TABLET;ORAL	Discontinued	None	No	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 012265

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/09/1960	ORIG-1	Approval	Type 1 - New Molecular Entity	STANDARD		Label is not available on this site.